Medplus Health Services cash flow

Latest FY26

Cash from operations: ₹496cr−8.3% on FY25
Capital spending: ₹123cr+106.9% on FY25
Free cash flow: ₹373cr−22.5% on FY25
Cash from financing: −₹256cr−₹228 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	283	250	224	182
	—	0.0	0.1	96.4	83.0
	—	0.0	−26.0	−20.9	−27.8
	—	0.0	6.9	14.1	22.1
	—	118	98.6	16.8	13.4
	—	0.7	0.0	0.0	0.0
	—	−36.6	−4.9	−196	−229
	—	0.0	4.1	0.0	0.0
	—	0.0	−13.1	0.0	0.0
	—	−25.8	0.0	−10.8	16.3
	—	−24.8	0.0	−16.7	−20.1
	—	−10.7	0.1	−4.3	−10.0
	—	0.0	62.1	0.0	0.0
	—	19.9	0.0	0.9	27.8
	—	0.0	16.3	5.9	3.7
	—	−21.4	−16.1	−10.0	−4.1
	—	35.7	24.3	0.0	0.0
Cash from operating activities
	266	275	183	73.4	47.2
	—	338	402	99.5	57.2
	—	613	586	173	104
	—	−43.4	0.0	0.0	0.0
	—	74.1	45.2	29.2	13.9
	—	496	540	144	90.4
Cash from investing activities
	—	123	59.5	84.4	169
	—	0.4	1.0	1.6	0.2
	—	807	0.0	0.0	0.0
	—	771	0.0	0.0	0.0
	—	16.5	0.0	0.0	0.0
	—	16.5	0.0	0.0	0.0
	—	31.5	14.0	13.6	21.3
	—	0.0	−273	−13.6	577
	—	−128	−318	−82.8	429
Cash from financing activities
	—	9.9	4.6	7.2	1.2
	—	265	130	109	88.4
	—	0.0	103	96.4	83.0
	—	0.0	−0.1	0.0	0.0
	—	−256	−228	−198	−170
	—	112	−5.2	−137	350
	—	112	−5.2	−137	350
	—	198	86.1	91.2	228
Reference items
	631	607	487	354	266
	8.3%	8.8%	7.9%	6.3%	5.8%
	373	373	481	59.3	−78.6
	—	373	378	−37.1	—
	₹31.03	₹31.03	₹40.06	₹4.94	−₹6.55
	19.27×	—	—	—	—
	—	2.26×	3.60×	2.19×	1.80×
	—	74.1	45.2	29.2	13.9
	—	0.0	103	96.4	83.0

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MEDPLUS₹598.05

Medplus Health Services Ltd.

· Consumer Services

₹ CrorePeersAPOLLOHOSP MANYAVAR MSTCLTD NESCO JUSTDIAL JSLL QUESS IXIGOMcap ₹7,180 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	182.0	224.2	249.8	282.9	—
+ Finance Costs	83.0	96.4	0.1	0.0	—
+ Interest Income	-27.8	-20.9	-26.0	0.0	—
+ Share-based Payments	22.1	14.1	6.9	0.0	—
+ Other Non-cash Items	13.4	16.8	98.6	117.6	—
+ Other Reconciling Items	0.0	0.0	0.0	0.7	—
Changes in Working Capital
+ Inventories	-229.1	-196.1	-4.9	-36.6	—
+ Trade Receivables — Current	0.0	0.0	4.1	0.0	—
+ Trade Receivables — Non-current	0.0	0.0	-13.1	0.0	—
+ Other Financial Assets — Current	16.3	-10.8	0.0	-25.8	—
+ Other Financial Assets — Non-current	-20.1	-16.7	0.0	-24.8	—
+ Other Current Assets	-10.0	-4.3	0.1	-10.7	—
+ Trade Payables — Current	0.0	0.0	62.1	0.0	—
+ Other Financial Liabilities — Current	27.8	0.9	0.0	19.9	—
+ Other Current Liabilities	3.7	5.9	16.3	0.0	—
+ Provisions — Current	-4.1	-10.0	-16.1	-21.4	—
+ Provisions — Non-current	0.0	0.0	24.3	35.7	—
Cash from Operating Activities
Profit Before Tax (per I/S)	47.2	73.4	183.3	275.3	265.7
+ Total Adjustments (incl. Working Capital)	57.2	99.5	402.4	337.7	—
Cash from Operations (pre-tax)	104.3	173.0	585.7	613.0	—
+ Interest Received — Operating	0.0	0.0	0.0	-43.4	—
+ Income Taxes Paid	13.9	29.2	45.2	74.1	—
Cash from Operating Activities	90.4	143.7	540.4	495.6	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	169.0	84.4	59.5	123.0	—
+ Disp of Fixed Assets	0.2	1.6	1.0	0.4	—
+ Acq of Other Long-term Assets	0.0	0.0	0.0	807.3	—
+ Disp of Other Long-term Assets	0.0	0.0	0.0	770.7	—
+ Purchase of Investments (Equity / Debt)	0.0	0.0	0.0	16.5	—
+ Sale of Investments (Equity / Debt)	0.0	0.0	0.0	16.5	—
+ Interest Received — Investing	21.3	13.6	14.0	31.5	—
+ Other Inflows / (Outflows) — Investing	577.0	-13.6	-273.2	0.0	—
Cash from Investing Activities	429.4	-82.8	-317.6	-127.7	—
Cash from Financing Activities
+ Proceeds from Exercise of Stock Options	1.2	7.2	4.6	9.9	—
+ Payment of Lease Liabilities	88.4	108.9	130.0	265.4	—
+ Interest Paid	83.0	96.4	102.5	0.0	—
+ Other Inflows / (Outflows) — Financing	0.0	0.0	-0.1	0.0	—
Cash from Financing Activities	-170.2	-198.1	-228.0	-255.5	—
Net Changes in Cash (pre-FX)	349.6	-137.2	-5.2	112.4	—
Net Changes in Cash	349.6	-137.2	-5.2	112.4	—
Closing Cash	228.4	91.2	86.1	198.4	—
Reference Items
EBITDA	265.7	354.1	487.1	607.4	631.1
EBITDA Margin %	5.83	6.29	7.94	8.81	8.32
Free Cash Flow (CFO − Capex)	-78.6	59.3	481.0	372.6	372.6
Free Cash Flow to Equity	—	-37.1	378.5	372.5	—
Free Cash Flow per Basic Share	-6.55	4.94	40.06	31.03	31.03
Price to Free Cash Flow	—	—	—	—	19.27
Cash Flow to Net Income	1.80	2.19	3.60	2.26	—
Cash Paid for Taxes	13.9	29.2	45.2	74.1	—
Cash Paid for Interest	83.0	96.4	102.5	0.0	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.